48,830
edits
Line 161: | Line 161: | ||
===Classification=== | ===Classification=== | ||
Classification based on extent:<ref name=pmid21252716>{{cite journal |author=Travis WD, Brambilla E, Noguchi M, ''et al.'' |title=International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma |journal=J Thorac Oncol |volume=6 |issue=2 |pages=244–85 |year=2011 |month=February |pmid=21252716 |doi=10.1097/JTO.0b013e318206a221 |url=}}</ref> | Classification based on extent:<ref name=pmid21252716>{{cite journal |author=Travis WD, Brambilla E, Noguchi M, ''et al.'' |title=International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma |journal=J Thorac Oncol |volume=6 |issue=2 |pages=244–85 |year=2011 |month=February |pmid=21252716 |doi=10.1097/JTO.0b013e318206a221 |url=}}</ref> | ||
#Adenocarcinoma in situ (AIS) - previously known as [[BAC]]. | #Adenocarcinoma in situ (AIS) - previously known as ''bronchioloalveolar carcinoma'' (abbreviated [[BAC]]). | ||
#*Subtypes: nonmucinous, mucinous, mixed mucinous/nonmucinous. | #*Subtypes: nonmucinous, mucinous, mixed mucinous/nonmucinous. | ||
#*Definition: lack of invasion into the stroma, vascular spaces and pleura. | #*Definition: lack of invasion into the stroma, vascular spaces and pleura. |
edits